---
title: "GLORIA PHARMA released its first-quarter performance, with a net profit attributable to the parent company of 60.2523 million yuan, a year-on-year increase of 15.24%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237566642.md"
description: "According to the Zhitong Finance APP, GLORIA PHARMA released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 551 million yuan, a year-on-year decrease of 7.06%. The net profit attributable to shareholders of the listed company was 60.2523 million yuan, a year-on-year increase of 15.24%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 49.733 million yuan, a year-on-year increase of 54.74%"
datetime: "2025-04-25T11:23:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237566642.md)
  - [en](https://longbridge.com/en/news/237566642.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237566642.md)
---

# GLORIA PHARMA released its first-quarter performance, with a net profit attributable to the parent company of 60.2523 million yuan, a year-on-year increase of 15.24%

According to the Zhitong Finance APP, GLORIA PHARMA (002437.SZ) released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 551 million yuan, a year-on-year decrease of 7.06%. The net profit attributable to shareholders of the listed company was 60.2523 million yuan, a year-on-year increase of 15.24%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 49.733 million yuan, a year-on-year increase of 54.74%

### Related Stocks

- [002437.CN](https://longbridge.com/en/quote/002437.CN.md)

## Related News & Research

- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [REG - Nomura Intl. PLC Spire Healthcare Grp - Form 8.3 - SPIRE HEALTHCARE GROUP PLC](https://longbridge.com/en/news/296096467.md)
- [06:58 ETCapitan Orthopedics, Inc. Announces the Closing of Their Oversubscribed Seed Round](https://longbridge.com/en/news/296217753.md)
- [Bioz and Xenocs Improve Researcher Product Evaluation Through On-Page Publication Insights](https://longbridge.com/en/news/296195684.md)
- [Singapore's OUE strengthens China presence with Shenzhen flagship](https://longbridge.com/en/news/296056716.md)